drugset / Trial / NCT00301080

D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain

NCT00301080

Phase 3 Terminated 7 enrolled Northwestern University
RandomizedParallel-groupDouble-blindSupportive care

Summary

D-cycloserine may help lessen pain and other symptoms of peripheral neuropathy caused by chemotherapy. It is not yet known whether D-cycloserine is more effective than a placebo in treating peripheral neuropathy caused by chemotherapy. This randomized, double-blind, placebo-controlled clinical trial was designed to study D-cycloserine at 2 different doses to see how well each works compared to the other and to a placebo in treating cancer patients with peripheral neuropathy caused by chemotherapy.

Timeline

Start
2006-02
Primary completion
2007-02
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cycloserine Small molecule 50 mg Oral
Comparator Cycloserine Small molecule 200 mg Oral
Comparator Cycloserine Small molecule 250 mg Oral